Sano Stemedica Cell Development: Our Product, Sano Stemedica Cells, is designed for treating diseases in neurological, inflammatory and immune, and cardiovascular disease areas.
Clinical Trials: The company works with independent clinical and research institutions both in the India, U.S. and internationally to establish trials
Cell Expansion: Stem cells can be expanded in large quantities after being isolated from a donor, enabling the production of vast quantities (hundreds of thousands to millions) of doses, making it a substantial source of therapy.
No Genetic Modification: The stem cells used are unmodified, and each batch is characterized for consistency and tolerability.
Multipotent Adult Progenitor Cells (MAPC®): The source of these stem cells is from healthy adult bone marrow, which can be expanded and used without the need for tissue matching or immune suppression.
